Literature DB >> 30600540

Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density.

Alessandro Mantovani1, Marco Dauriz1, Davide Gatti2, Ombretta Viapiana2, Giacomo Zoppini1, Giuseppe Lippi3, Christopher D Byrne4,5, Fabrice Bonnet6, Enzo Bonora1, Giovanni Targher1.   

Abstract

BACKGROUND: Several studies have explored the effect of non-alcoholic fatty liver disease (NAFLD) on bone mineral density (BMD) and risk of osteoporotic fractures in adults. However, the extent to which NAFLD adversely affects bone health remains uncertain. AIM: To provide a quantitative estimation of the magnitude of the association of NAFLD with BMD or history of osteoporotic fractures in adults.
METHODS: We searched PubMed, Web of Science, and Scopus using predefined keywords to identify all observational studies, published up to 31 August 2018, in which NAFLD was diagnosed by imaging or histology; BMD was measured by dual energy X-ray absorptiometry; and a self-reported history of osteoporotic fractures was collected with interviewer-assisted questionnaires. Data from selected studies were extracted, and meta-analysis was performed using random-effects modelling.
RESULTS: Twelve cross-sectional or case-control studies with aggregate data on 30 041 adults of predominantly Asian ethnicity (30% with NAFLD) were included in the final analysis. No significant differences in BMD at different skeletal sites (whole body, lumbar spine, or femur) were observed between individuals with and without NAFLD. Conversely, NAFLD was associated with increased odds of osteoporotic fractures, especially in older Chinese men (n = 2 studies; random-effects odds ratio 2.10, 95% CI 1.36-3.25; I2  = 0%). Sensitivity analyses did not alter these findings. The funnel plot and Egger test did not reveal significant publication bias.
CONCLUSIONS: This meta-analysis suggests that imaging-defined or biopsy-proven NAFLD is associated with a self-reported history of osteoporotic fractures (principally in Chinese men), but not with low BMD, in middle-aged and elderly individuals.
© 2019 John Wiley & Sons Ltd.

Entities:  

Year:  2019        PMID: 30600540     DOI: 10.1111/apt.15087

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

Review 1.  Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Binjing Pan; Jing Cai; Pingping Zhao; Jingfang Liu; Songbo Fu; Gaojing Jing; Qianglong Niu; Qiong Li
Journal:  Osteoporos Int       Date:  2022-06-28       Impact factor: 5.071

2.  Increased risk of non-alcoholic fatty liver disease fibrosis is closely associated with osteoporosis in women but not in men with type 2 diabetes.

Authors:  Zhiyan Yu; Yueyue Wu; Rui Zhang; Yue Li; Shufei Zang; Jun Liu
Journal:  Endocr Connect       Date:  2022-10-12       Impact factor: 3.221

3.  Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses.

Authors:  Lixian Zhong; Chutian Wu; Yuting Li; Qiuting Zeng; Leizhen Lai; Sisi Chen; Shaohui Tang
Journal:  Ther Adv Chronic Dis       Date:  2022-05-19       Impact factor: 4.970

Review 4.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

5.  Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort.

Authors:  Belinda T Li; Tracey G Simon; Na Wang; Raymond T Chung; Kathleen E Corey; Laura E Dichtel; Elizabeth J Samelson; Douglas P Kiel; Michelle T Long
Journal:  Obesity (Silver Spring)       Date:  2021-02-02       Impact factor: 5.002

6.  Association of Bone Metabolism with Fatty Liver Disease in the Elderly in Japan: A Community-based Study.

Authors:  Kenichiro Mikami; Tetsu Endo; Naoya Sawada; Go Igarashi; Masayo Kimura; Takuma Hasegawa; Chikara Iino; Kaori Sawada; Shigeyuki Nakaji; Yasuyuki Ishibashi; Masashi Matsuzaka; Shinsaku Fukuda
Journal:  Intern Med       Date:  2020-02-26       Impact factor: 1.271

7.  Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005-2014.

Authors:  Tianyu Zhai; Qi Chen; Jing Xu; Xi Jia; Pu Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-19       Impact factor: 5.555

8.  Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study.

Authors:  Axel Wester; Hannes Hagström
Journal:  J Intern Med       Date:  2022-04-19       Impact factor: 13.068

9.  Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes.

Authors:  Ningjian Wang; Yuying Wang; Xiaoman Chen; Wen Zhang; Yi Chen; Fangzhen Xia; Heng Wan; Qing Li; Boren Jiang; Bin Hu; Yingli Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-28       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.